Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Mallinckrodt
Dow
Colorcon

Last Updated: August 17, 2022

Investigational Drug Information for Asoprisnil


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Asoprisnil?

Asoprisnil is an investigational drug.

There have been 15 clinical trials for Asoprisnil. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2003.

The most common disease conditions in clinical trials are Myofibroma, Leiomyoma, and Menorrhagia. The leading clinical trial sponsors are Abbott, Jenapharm GmbH & Co. KG, and TAP Pharmaceutical Products Inc.

Recent Clinical Trials for Asoprisnil
TitleSponsorPhase
Study of Asoprisnil in the Treatment of Uterine Fibroids.AbbottPhase 3
Safety of Treatment of Uterine Fibroids With AsoprisnilAbbottPhase 3
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine FibroidsAbbottPhase 3

See all Asoprisnil clinical trials

Clinical Trial Summary for Asoprisnil

Top disease conditions for Asoprisnil
Top clinical trial sponsors for Asoprisnil

See all Asoprisnil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Mallinckrodt
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.